Cell-free DNA (cfDNA) landscape in ERBB2 (HER2)-amplified Asian cancer patient population
Lee, J., Franovic, A., Rich, T.A., Shiotsu, Y., Raymond, V.M., Lanman, R.B.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Circulating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types
Ikeda, S., Kumaki, Y., Rich, T.A., Shiotsu, Y., Franovic, A., Raymond, V.M., Kurzrock, R., Lanman, R.B., Lee, J., Mok, T.S.K.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
RXDX-106 Is an orally-available, potent and selective TAM/MET inhibitor demonstrating preclinical efficacy in MET-dependent human malignancies
Franovic, A, Schairer, A.E, Uryu, S, Falk, M.D, Li, G.G, Albert, A, Martin, E
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA)
Catenacci, D.V.T., Park, H., Uronis, H.E., Kang, Y.-K., Ng, M., Gold, P., Lacy, J., Enzinger, P.C., Park, S., Lee, K.-W., Yen, J., Odegaard, J., Franovic, A., Baughman, J., Muth, J., Wynter-Horton, A., Wu, T., Wigginton, J., Davidson-Moncada, J.K., Bang, Y.-J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
RXDX-105 demonstrates anti-tumor efficacy in multiple preclinical cancer models driven by molecular alterations in RET or BRAF oncogenes
Martin, L, Walsh, C, Uryu, S, Joseph, J, Franovic, A, Schairer, A, Patel, R, Shoemaker, R, Diliberto, A, Murphy, D, Christiansen, J, Oliver, J, Kowack, E, Multani, P, Li, G.G
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
40P Real-world clinical genomic analysis of patients with BRAF mutated cancers identifies BRAF class II and III as a population of unmet medical need
Severson, P., Kellner, W., Franovic, A., Miller, N., Murphy, E., Martin, E.S., Williams, R.
Published in Annals of oncology (01.03.2022)
Published in Annals of oncology (01.03.2022)
Get full text
Journal Article
373PCell-free DNA (cfDNA) landscape in ERBB2 (HER2)-amplified Asian cancer patient population
Lee, J, Franovic, A, Rich, T A, Shiotsu, Y, Raymond, V M, Lanman, R B
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Abstract P3-06-05: Not presented
Croucher, PJP, Franovic, A, Ballinari, D, Gasparri, F, Giorgini, L, Whitley, P, Valsasina, B, Erlander, MG
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
65 - RXDX-106 Is an orally-available, potent and selective TAM/MET inhibitor demonstrating preclinical efficacy in MET-dependent human malignancies
Franovic, A., Schairer, A.E., Uryu, S., Falk, M.D., Li, G.G., Albert, A., Martin, E.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
378PCirculating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types
Ikeda, S, Kumaki, Y, Rich, T A, Shiotsu, Y, Franovic, A, Raymond, V M, Kurzrock, R, Lanman, R B, Lee, J, Mok, T S K
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types
Kuziora, M., Si, H., Higgs, B., Brohawn, P., Streicher, K., Jure-Kunkel, M., Raja, R., Helman, E., Franovic, A., Cooper, Z., Shrestha, Y., Holoweckyj, N., Lee, Y., Achour, I., Ye, J., Mukhopadhyay, P., Dennis, P.A., Melillo, G., Abdullah, S.E., Ranade, K.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)
Park, H., Uronis, H., Kang, Y.-K., Ng, M.C.H., Enzinger, P., Lee, K.W., Rutella, S., Church, S.E., Nordstrom, J., Knutson, K., Erskine, C., Wu, T., Yen, J., Franovic, A., Muth, J., Rosales, M., Vadakekolathu, J., Davidson-Moncada, J., Bang, Y.-J., Catenacci, D.V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1189PD - Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)
Park, H., Uronis, H., Kang, Y.-K., Ng, M.C.H., Enzinger, P., Lee, K.W., Rutella, S., Church, S.E., Nordstrom, J., Knutson, K., Erskine, C., Wu, T., Yen, J., Franovic, A., Muth, J., Rosales, M., Vadakekolathu, J., Davidson-Moncada, J., Bang, Y.-J., Catenacci, D.V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1189PDDeterminants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)
Park, H, Uronis, H, Kang, Y-K, Ng, M C H, Enzinger, P, Lee, K W, Rutella, S, Church, S E, Nordstrom, J, Knutson, K, Erskine, C, Wu, T, Yen, J, Franovic, A, Muth, J, Rosales, M, Vadakekolathu, J, Davidson-Moncada, J, Bang, Y-J, Catenacci, D V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
2OSomatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types
Kuziora, M, Si, H, Higgs, B, Brohawn, P, Streicher, K, Jure-Kunkel, M, Raja, R, Helman, E, Franovic, A, Cooper, Z, Shrestha, Y, Holoweckyj, N, Lee, Y, Achour, I, Ye, J, Mukhopadhyay, P, Dennis, P A, Melillo, G, Abdullah, S E, Ranade, K
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
662PBiomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA)
Catenacci, D V T, Park, H, Uronis, H E, Kang, Y-K, Ng, M, Gold, P, Lacy, J, Enzinger, P C, Park, S, Lee, K-W, Yen, J, Odegaard, J, Franovic, A, Baughman, J, Muth, J, Wynter-Horton, A, Wu, T, Wigginton, J, Davidson-Moncada, J K, Bang, Y-J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer
Smith, Karlene, Gunaratnam, Lakshman, Morley, Melissa, Franovic, Aleksandra, Mekhail, Karim, Lee, Stephen
Published in Cancer research (Chicago, Ill.) (15.06.2005)
Published in Cancer research (Chicago, Ill.) (15.06.2005)
Get full text
Journal Article
85 - RXDX-105 demonstrates anti-tumor efficacy in multiple preclinical cancer models driven by molecular alterations in RET or BRAF oncogenes
Martin, L., Walsh, C., Uryu, S., Joseph, J., Franovic, A., Schairer, A., Patel, R., Shoemaker, R., Diliberto, A., Murphy, D., Christiansen, J., Oliver, J., Kowack, E., Multani, P., Li, G.G.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells
Gunaratnam, Lakshman, Morley, Melissa, Franovic, Aleksandra, de Paulsen, Natalie, Mekhail, Karim, Parolin, Doris A.E., Nakamura, Eijiro, Lorimer, Ian A.J., Lee, Stephen
Published in The Journal of biological chemistry (07.11.2003)
Published in The Journal of biological chemistry (07.11.2003)
Get full text
Journal Article